Investor profile
Christopher Haddad
Private equity, Venture debt & Principal at Janus Henderson Investors
Christopher Haddad is a Principal at Janus Henderson Investors, whose known portfolio counts 10 companies.
Is Christopher Haddad a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- FinTechHealthcare
Contacts
Affiliated funds' portfolios
Principal at Janus Henderson Investors, whose known portfolio counts 10 companies
- Relmada Therapeutics
- Achieve Life Science
- Ray Therapeutics
- Ovid Therapeutics
- Solid Biosciences
- Maze Therapeutics
- Ambrosia Biosciences
- Calyxo
- Adagene
- Longeveron
Investor Profile
Christopher Haddad is listed against sectors FinTech and Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and MedTech in the database.
Janus Henderson Investors appears in Growth, Late-Stage and Series B rounds across its known deals.
What the affiliated firm has backed is the closest available signal on whether Christopher Haddad is worth approaching.
Colleagues at Janus Henderson Investors
Henrik Krasilnikoff Jeppesen
Senior Member
Denver, United States
Noe Marquez
Investment Service Analyst
Denver, United States
Belinda Martha Mongoyo
Angel Investors
United States
Yaser Moustafa
Head of EM Private Investments
United Arab Emirates
Rupert Pennant Rea
Chairman
London, United Kingdom
Erdem Kilic
Senior Director
Frankfurt, Germany
Karen Silaika
Associate Director (Georgia)
Denver, United States
Cara Owen
Senior Legal Counsel
Denver, United States
Frequently asked questions
Who is Christopher Haddad?
Christopher Haddad is a private equity investor and venture debt investor based in United Arab Emirates, listed as Principal at Janus Henderson Investors. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Christopher Haddad personally.
What does Christopher Haddad invest in?
Listed sectors include FinTech and Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and MedTech. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Christopher Haddad invest at?
Janus Henderson Investors appears in Growth, Late-Stage and Series B rounds across its known deals, and Christopher Haddad is listed there as Principal. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Christopher Haddad listed at?
Christopher Haddad is listed as Principal at Janus Henderson Investors. 8 other people in the database share a firm with Christopher Haddad.
How do I contact Christopher Haddad?
An email address, a phone number and a LinkedIn page are on file for Christopher Haddad. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal